Literature DB >> 229118

Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects.

K Nakao, Y Nakai, H Jingami, S Oki, J Fukata, H Imura.   

Abstract

To elucidate whether insulin-induced hypoglycemia enhances the release of beta-endorphin in man, plasma extracts obtained from healthy subjects and patients with Graves' disease before and 45 min after insulin injection were subjected to gel chromatography, and the fractions obtained were measured by RIA for beta-endorphin. In four healthy subjects, basal plasma beta-endorphin levels were less than 3 to 3.1 pg/ml, and the levels rose substantially to 47.5 +/- 12.4 pg/ml (mean +/- SE) 45 min after insulin injection. Basal plasma beta-endorphin levels in three hyperthyroid patinets (less than 3 to 3.8 pg/ml) did not seem to be different from those in healthy subjects; however, the rise after insulin injection tended to be higher in cases of hyperthyroidism, with a peak value of 68.5 +/- 9.7 pg/ml. Plasma beta-lipotropin and ACTH levels also rose in parallel with beta-endorphin in response to insulin-induced hypoglycemia in both healthy subjects and hyperthyroid patients. It would thus appear that beta-endorphin, like ACTH or beta-lipotropin, is released in human subjects by hypoglycemic stress.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229118     DOI: 10.1210/jcem-49-6-838

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

2.  Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade.

Authors:  James Leu; Min-Hui Cui; Harry Shamoon; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

3.  Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy.

Authors:  M B Max
Journal:  Anesth Prog       Date:  1987-07

4.  Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.

Authors:  Sarita Naik; Renata Belfort-DeAguiar; Anne-Sophie Sejling; Barbara Szepietowska; Robert S Sherwin
Journal:  Diabetes Obes Metab       Date:  2017-02-17       Impact factor: 6.577

5.  Psychoneuroendocrinology, biorhythms, and Chinese medicine.

Authors:  C C Bell
Journal:  J Natl Med Assoc       Date:  1981-01       Impact factor: 1.798

6.  Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus.

Authors:  Septimiu Vele; Sofiya Milman; Harry Shamoon; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

7.  Beta endorphin selectively stimulates aldosterone secretion in hypophysectomized, nephrectomized dogs.

Authors:  H G Güllner; J R Gill
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

8.  Immunoreactive beta-endorphin and adrenocorticotropin in human cerebrospinal fluid.

Authors:  K Nakao; S Oki; I Tanaka; K Horii; Y Nakai; T Furui; M Fukushima; A Kuwayama; N Kageyama; H Imura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

9.  Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.

Authors:  X Y Bertagna; W J Stone; W E Nicholson; C D Mount; D N Orth
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  Stress hormones in accident patients studied before admission to hospital.

Authors:  W Hetz; H D Kamp; U Zimmermann; A von Bohlen; L Wildt; J Schuettler
Journal:  J Accid Emerg Med       Date:  1996-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.